CTI BioPharma Corp. Gains 85.27%
Wed, May 10, 2023 at 07:34 PM
CTI BioPharma Corp. (CTIC:NASDAQ) rocketted at $8.93, representing a gain of 85.3%. On Wed, May 10, 2023, CTIC:NASDAQ touched a New 2-Week High of $8.93. The stock appeared on our News Catalysts scanner on Wed, May 10, 2023 at 11:28 AM in the 'MISCELLANEOUS' category. From Wed, Apr 26, 2023, the stock recorded 50.00% Up Days and 54.55% Green Days
About CTI BioPharma Corp. (CTIC:NASDAQ)
CTI BioPharma Corp is a biopharmaceutical company. It is focused on the acquisition, development and commercialization of novel targeted therapies.
Top 10 Gainers:
- CTI BioPharma Corp. (CTIC:NASDAQ), 85.27%
- iMedia Brands, Inc. (IMBI:NASDAQ), 82.5%
- Harbor Custom Development Inc. (HCDI:NASDAQ), 80.08%
- Unique Fabricating, Inc. (UFAB:NYSEMKT), 75.61%
- Inspirato Inc Cl A (ISPO:NASDAQ), 47.63%
- Microvast Holdings Inc. (MVST:NASDAQ), 42.75%
- TScan Therapeutics Inc. (TCRX:NASDAQ), 42.65%
- Xometry Inc. (XMTR:NASDAQ), 39.91%
- Benson Hill Inc. (BHIL:NYSE), 38.21%
- Compass Inc. Class A (COMP:NYSE), 35%